*Disclosure: This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. We only recommend books we genuinely believe in.
Quick Overview
Aswath Damodaran is Professor of Finance at NYU Stern School of Business and the world's most prolific author on valuation. His textbooks (Investment Valuation, Damodaran on Valuation) are 800-1000 page graduate-level references. The Little Book of Valuation is his condensed version for the intelligent non-specialist — covering the full valuation toolkit in 256 accessible pages. If you want to learn to value companies without going to business school, this is the best place to start.
Book Details
| Attribute | Details |
|---|
| Title | The Little Book of Valuation |
| Author | Aswath Damodaran |
| Publisher | Wiley |
| Published | 2011 |
| Pages | 256 |
| Reading Level | Intermediate |
| Amazon Rating | 4.5/5 stars |
Get Your Copy
Hardcover: Buy on Amazon
Kindle: Buy on Amazon
About the Author
Aswath Damodaran is a professor at NYU Stern School of Business where he has taught valuation for over 30 years. He maintains a publicly accessible website (damodaran.com) that provides free valuation data, templates, and lecture notes for every industry and country. He values companies publicly — Apple, Amazon, Tesla, Uber at various stages — and explains his assumptions transparently. He is universally regarded as the most accessible and intellectually honest practitioner of valuation analysis.
The Valuation Philosophy
Damodaran opens with a critical philosophical point: valuation is not precise. Any valuation produces a range of outcomes, not a single right answer. Models require assumptions about the future that are inherently uncertain.
The three types of valuation:
| Type | Approach | When Used |
|---|
| Intrinsic (DCF) | Present value of future cash flows | When you want to know what a company is worth independent of market opinion |
| Relative | Compare to peers using multiples (P/E, EV/EBITDA) | When you want to know if a company is cheap or expensive vs. the market |
| Option-based | Value flexibility using option pricing | For companies with significant optionality (distressed firms, natural resources, pharmaceutical pipelines) |
Most investors should focus on DCF and relative valuation. Option-based valuation requires more technical machinery.
Intrinsic Valuation: The DCF Framework
The Foundation: Present Value
The value of any asset equals the present value of all future cash flows it will generate, discounted at an appropriate rate.
Value = CF₁/(1+r) + CF₂/(1+r)² + CF₃/(1+r)³ + ... + CFₙ/(1+r)ⁿ
Where:
CF = Cash flow in each periodr = Discount rate (required return)n = Number of periodsStep 1: Estimate Cash Flows
Damodaran uses Free Cash Flow to Firm (FCFF) as the primary cash flow measure:
FCFF = EBIT × (1 - tax rate)
+ Depreciation & Amortization
- Capital Expenditures
- Change in Working Capital
The reinvestment rate:
Not all earnings are available to distribute — companies must reinvest some to grow. The reinvestment rate determines how much of earnings returns to investors vs. funds growth:
Reinvestment Rate = (Capex - Depreciation + Change in Working Capital) / EBIT(1-t)
A company that must reinvest 70% of after-tax earnings to grow at 10% has less intrinsic value than one that can grow at 10% while reinvesting only 30%.
Step 2: Estimate the Discount Rate (WACC)
The Weighted Average Cost of Capital (WACC) represents the blended required return for debt and equity investors:
WACC = (E/V) × Ke + (D/V) × Kd × (1 - tax rate)
Where:
E/V = Equity as a proportion of total valueKe = Cost of equityD/V = Debt as a proportion of total valueKd = Pre-tax cost of debtEstimating the cost of equity using CAPM:
Ke = Risk-Free Rate + Beta × Equity Risk Premium
| Component | Typical Values (2024) |
|---|
| Risk-Free Rate (10-yr Treasury) | 4.5% |
| Equity Risk Premium (U.S.) | 4.5-5.5% |
| Beta (market-average) | 1.0 |
| Beta (low-risk consumer staples) | 0.5-0.7 |
| Beta (high-growth tech) | 1.3-2.0 |
Example — stable consumer brand:
Ke = 4.5% + 0.65 × 5.0% = 7.75%
WACC (with 20% debt at 5% pre-tax, 25% tax) =
0.80 × 7.75% + 0.20 × 5.0% × (1-0.25) = 6.95%
Step 3: Estimate Terminal Value
Most of a company's value comes from cash flows beyond the explicit forecast period. The terminal value captures this:
Terminal Value = FCFFₙ × (1 + g) / (WACC - g)
Where g = perpetual growth rate (typically 2-3%, close to long-run GDP growth)
The terminal value sensitivity problem:
Terminal value typically accounts for 60-80% of total DCF value. A small change in the terminal growth rate or discount rate produces large changes in estimated value:
| Terminal Growth Rate | WACC 7% | WACC 8% | WACC 9% |
|---|
| 2% | 20.0x | 16.7x | 14.3x |
| 3% | 25.0x | 20.0x | 16.7x |
| 4% | 33.3x | 25.0x | 20.0x |
(Multiples of normalized free cash flow)
Damodaran's guidance: Use conservative terminal assumptions (g = 2-3% maximum; no company grows faster than the economy forever). This creates a margin of safety built into the terminal value assumption.
Relative Valuation: The Multiples Framework
Price-to-Earnings (P/E) Ratio
The most widely used valuation multiple. Compares the stock price to earnings per share.
P/E = Price / Earnings per Share
Interpreting P/E:
A high P/E means investors are paying more for each dollar of current earnings, typically because:
High expected future earnings growthHigh quality/certainty of earningsLow interest rate environment (which makes all future cash flows worth more today)The PEG ratio (adjusting for growth):
PEG = P/E / Expected Earnings Growth Rate
A company trading at 20x earnings with 20% expected growth has a PEG of 1.0. A company trading at 20x earnings with 10% expected growth has a PEG of 2.0 — more expensive on a growth-adjusted basis.
P/E by sector (approximate 2024 ranges):
| Sector | Typical P/E Range | Why |
|---|
| Utilities | 15-20x | Slow growth; stable regulated earnings |
| Consumer Staples | 20-25x | Stable earnings; moderate growth |
| Healthcare | 20-30x | Moderate growth; high quality |
| Technology (established) | 25-40x | Higher growth; high margins |
| High-growth software | 40-100x+ | Revenue growth prioritized over current profit |
Enterprise Value / EBITDA
EV/EBITDA is preferred over P/E for many analyses because it:
Is capital structure neutral (compares companies with different debt levels)Is less affected by one-time itemsWorks for companies with zero or negative earningsEnterprise Value = Market Cap + Total Debt - Cash
EV/EBITDA = Enterprise Value / EBITDA
EV/EBITDA norms by sector:
| Sector | Typical EV/EBITDA |
|---|
| Telecommunications | 5-8x |
| Retail | 6-10x |
| Industrial | 8-12x |
| Healthcare services | 10-15x |
| Software (SaaS) | 15-30x |
| Technology platforms | 25-50x+ |
Price-to-Book (P/B)
P/B = Market Price / Book Value per Share
P/B is most useful for financial companies (banks, insurance companies) where balance sheet assets closely approximate replacement value.
P/B benchmarks:
P/B < 1.0: Trading below liquidation value (potential deep value or distress signal)P/B 1-3x: Moderate premium to book; normal for most industriesP/B > 10x: Significant intangible value (brand, software, intellectual property)Price-to-Sales (P/S)
Used for companies with no current earnings — particularly high-growth technology, biotech, and turnaround situations.
P/S = Market Cap / Annual Revenue
Interpreting P/S:
| P/S Multiple | Typical Context |
|---|
| Below 0.5x | Very cheap; potential distress or declining business |
| 0.5-2x | Mature, lower-margin businesses |
| 2-5x | Moderate-growth with decent margins |
| 5-15x | High-growth with path to strong margins |
| Above 15x | Hyper-growth; priced for dominant market position |
Valuation by Company Type
Damodaran dedicates chapters to the unique challenges of valuing different types of companies:
Valuing Young/High-Growth Companies
The challenge: most value is in the terminal value, which depends on assumptions about a future that is inherently uncertain.
Damodaran's approach:
Estimate the total addressable market (TAM) the company could eventually captureAssume a target market share in year 10 (the "steady state")Assume a target operating margin in year 10 consistent with comparable mature businessesBuild a revenue and margin pathway from today to year 10Apply a discount rate that reflects the high risk of not reaching the assumed endpointAdd a probability weight for the scenario the company fails entirelyKey sensitivities for growth companies:
| Assumption | Low Case | Base Case | High Case |
|---|
| Year 10 revenue | $5B | $15B | $50B |
| Year 10 operating margin | 10% | 20% | 30% |
| Discount rate | 12% | 10% | 8% |
| Resulting value | $20/share | $85/share | $350/share |
The enormous range illustrates why growth stock valuation is more art than science — and why margin of safety is essential.
Valuing Mature Companies
Mature companies are easier to value but require attention to:
Deteriorating competitive position: Value assumes current margins persist; if margins are compressing, apply haircutCapex discipline: Mature companies often need less reinvestment than their historical ratios suggestCapital return potential: Mature cash flows should increasingly be returned rather than reinvestedValuing Declining/Distressed Companies
For companies with negative earnings or declining revenues, standard multiples do not work. Damodaran's approach:
Estimate normalized cash flows (what the company earns if it survives)Apply a probability of survivalEstimate recovery value in liquidationWeighted value = (Probability survival × Going concern value) + (Probability failure × Liquidation value)
The Margin of Safety in Valuation
Damodaran explicitly addresses the need for a margin of safety:
Every DCF contains estimation error. The discount rate might be wrong by 1%. The terminal growth rate might be wrong by 0.5%. The near-term cash flows might be wrong by 20%.
The margin of safety principle applied:
If your DCF suggests intrinsic value of $100/share, do not pay $100. Pay $70-80 (a 20-30% discount) to account for model error.
The required margin of safety should be larger for:
Less predictable businesses (higher uncertainty)Companies with less track recordBusinesses in rapidly changing industriesAnd smaller for:
Highly predictable, utility-like cash flowsBusinesses with long operating historyIndustries with structural stability
Damodaran makes all his valuation templates available free on damodaran.com:
| Tool | Description |
|---|
| DCF model templates | Excel models for different company types |
| Data sets | Historical industry data for discount rates, growth rates, margins |
| Company-specific valuations | Damodaran's own valuations with full assumptions disclosed |
| Risk premium data | Historical and implied equity risk premiums by country |
These free resources make the book uniquely actionable — you can immediately implement the frameworks using professionally designed tools.
Strengths & Weaknesses
What We Loved
Most rigorous yet accessible valuation framework in a single short bookFree companion resources at damodaran.com extend the book's value enormouslyCompany-type specific guidance for growth, mature, declining, and financial companiesHonest about uncertainty — does not pretend valuation is more precise than it isWACC and terminal value are explained with unusual clarityAreas for Improvement
Some sections are dense and require multiple readingsPublished 2011 — examples need updating for current market conditionsThe "Little Book" format means some topics are summarized rather than fully developed
Who Should Read This Book
Highly Recommended For
Investors who want to learn to value individual stocksFinance students who want the practitioner's view of valuationAnyone who wants to move beyond P/E ratios to a more complete valuation frameworkBusiness owners who want to understand how their company might be valuedProbably Not For
Passive index investorsComplete beginners with no financial statement experience
Frequently Asked Questions
Q: Do I need to know accounting to use this book?
A: Yes, basic accounting knowledge is assumed. Understanding income statements and cash flow statements is necessary. Read Financial Statements by Ittelson first if you need the foundation.
Q: Is this enough to value companies or do I need Damodaran's longer books?
A: Sufficient for most investment decisions. His longer books (Investment Valuation) add nuance for complex situations — M&A, cross-border valuation, option pricing — but 80% of investors will never need that depth.
Final Verdict
Rating: 4.6/5
The Little Book of Valuation is the best single-volume valuation guide for investors. Its DCF framework, relative valuation multiples, and company-type-specific guidance provide a complete toolkit. Combined with the free resources at damodaran.com, it is the most actionable valuation education available outside of formal business school training.
Get Your Copy
Hardcover: Buy on Amazon
Kindle: Buy on Amazon
Prices current as of publication date. Free shipping available with Prime.